leisure time -WSS

leisure time

author：knowledge 2025-10-01 18:07:27 - browse：5878

The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges.

The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

WSS

With psoriasis trial ahead, Alumis raises $259 million

Philips to halt sales of sleep apnea machines in U.S.

The problem with charging patients to message their doctors

First medicine developed to treat MASH expected to be approved soon

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

knowledge

leisure time

focus

Medical leaders decry Supreme Court decision on affirmative action

Investment in vaccine development is lagging, report finds

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Change Healthcare cyberattack prompts Medicare loan program

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Syphilis numbers in the United States reach record heights

In age of alternative facts, a scholarly course on calling out crap

IVF, abortion rights issues kick off Biden’s State of the Union

Bright Health sells Medicare Advantage business to Molina

The drug industry has found itself all alone in Washington

knowledge

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Amylyx ALS drug fails large clinical trial

NEJM study link tiny plastics in blood vessels to heart problems

Wegovy leads to weight loss. Can it treat depression, too?

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Wegovy leads to weight loss. Can it treat depression, too?

entertainment

focus

hotspot

knowledge